Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sebastian Oltean

Showing results (31-40 of 54) with videos related to

Pageof 6
Sort By:
Nephron|February 3, 2018
Vascular Endothelial Growth Factor-A165b Restores Normal Glomerular Water Permeability in a Diphtheria-Toxin Mouse Model of Glomerular InjuryMegan Stevens, Christopher R Neal, Andrew H J Salmon, et al.
Translational Oncology|October 9, 2018
The Evolutionarily Conserved Cassette Exon 7b Drives ERG's Oncogenic PropertiesSamantha L Jumbe, Sean R Porazinski, Sebastian Oltean, et al.
American Journal of Cancer Research|August 14, 2015
Circulating levels of anti-angiogenic VEGF-A isoform (VEGF-Axxxb) in colorectal cancer patients predicts tumour VEGF-A ratiosJohn Bunni, Golda Shelley-Fraser, Kirsty Stevenson, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 12, 2006
Alternative inclusion of fibroblast growth factor receptor 2 exon IIIc in Dunning prostate tumors reveals unexpected epithelial mesenchymal plasticitySebastian Oltean, Brian S Sorg, Todd Albrecht, et al.
Cancer Letters|June 13, 2017
The small molecule inhibitor YK-4-279 disrupts mitotic progression of neuroblastoma cells, overcomes drug resistance and synergizes with inhibitors of mitosisMadhu Kollareddy, Alice Sherrard, Ji Hyun Park, et al.
Oncogenesis|May 4, 2021
A drug-repositioning screen using splicing-sensitive fluorescent reporters identifies novel modulators of VEGF-A splicing with anti-angiogenic propertiesEleanor Star, Megan Stevens, Clare Gooding, et al.
Cancers|November 27, 2025
Niclosamide and Palbociclib Act Synergistically to Reduce Cholangiocarcinoma Cell Viability In Vitro and Inhibit Tumour Growth in a Mouse ModelGrace Martin, Ka Ying Lee, Christopher Roberts, et al.
Cancer Research|December 18, 2019
A Runaway PRH/HHEX-Notch3-Positive Feedback Loop Drives Cholangiocarcinoma and Determines Response to CDK4/6 InhibitionPhilip Kitchen, Ka Ying Lee, Danielle Clark, et al.
Biochemical Society Transactions|July 24, 2012
SRPK1 inhibition in vivo: modulation of VEGF splicing and potential treatment for multiple diseasesSebastian Oltean, Melissa Gammons, Richard Hulse, et al.
American Journal of Physiology. Renal Physiology|July 20, 2012
VEGF165b overexpression restores normal glomerular water permeability in VEGF164-overexpressing adult miceSebastian Oltean, Christopher R Neal, Athina Mavrou, et al.
Pageof 6

Showing results (31-40 of 54) with videos related to

Sort By:
Pageof 6
Nephron|February 3, 2018
Vascular Endothelial Growth Factor-A165b Restores Normal Glomerular Water Permeability in a Diphtheria-Toxin Mouse Model of Glomerular InjuryMegan Stevens, Christopher R Neal, Andrew H J Salmon, et al.
Translational Oncology|October 9, 2018
The Evolutionarily Conserved Cassette Exon 7b Drives ERG's Oncogenic PropertiesSamantha L Jumbe, Sean R Porazinski, Sebastian Oltean, et al.
American Journal of Cancer Research|August 14, 2015
Circulating levels of anti-angiogenic VEGF-A isoform (VEGF-Axxxb) in colorectal cancer patients predicts tumour VEGF-A ratiosJohn Bunni, Golda Shelley-Fraser, Kirsty Stevenson, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 12, 2006
Alternative inclusion of fibroblast growth factor receptor 2 exon IIIc in Dunning prostate tumors reveals unexpected epithelial mesenchymal plasticitySebastian Oltean, Brian S Sorg, Todd Albrecht, et al.
Cancer Letters|June 13, 2017
The small molecule inhibitor YK-4-279 disrupts mitotic progression of neuroblastoma cells, overcomes drug resistance and synergizes with inhibitors of mitosisMadhu Kollareddy, Alice Sherrard, Ji Hyun Park, et al.
Oncogenesis|May 4, 2021
A drug-repositioning screen using splicing-sensitive fluorescent reporters identifies novel modulators of VEGF-A splicing with anti-angiogenic propertiesEleanor Star, Megan Stevens, Clare Gooding, et al.
Cancers|November 27, 2025
Niclosamide and Palbociclib Act Synergistically to Reduce Cholangiocarcinoma Cell Viability In Vitro and Inhibit Tumour Growth in a Mouse ModelGrace Martin, Ka Ying Lee, Christopher Roberts, et al.
Cancer Research|December 18, 2019
A Runaway PRH/HHEX-Notch3-Positive Feedback Loop Drives Cholangiocarcinoma and Determines Response to CDK4/6 InhibitionPhilip Kitchen, Ka Ying Lee, Danielle Clark, et al.
Biochemical Society Transactions|July 24, 2012
SRPK1 inhibition in vivo: modulation of VEGF splicing and potential treatment for multiple diseasesSebastian Oltean, Melissa Gammons, Richard Hulse, et al.
American Journal of Physiology. Renal Physiology|July 20, 2012
VEGF165b overexpression restores normal glomerular water permeability in VEGF164-overexpressing adult miceSebastian Oltean, Christopher R Neal, Athina Mavrou, et al.
Pageof 6